Antivert Related Published Studies
Well-designed clinical trials related to Antivert (Meclizine)
Biphasic dosing regimen of meclizine for prevention of postoperative nausea and vomiting in a high-risk population. [2010.02]
Meclizine for prevention of nausea associated with use of emergency contraceptive pills: a randomized trial. [2000.02]
Central nervous system effects of meclizine and dimenhydrinate: evidence of acute tolerance to antihistamines. [1992.11]
Well-designed clinical trials possibly related to Antivert (Meclizine)
Various anti-motion sickness drugs and core body temperature changes. [2011.04]
No effects of anti-motion sickness drugs on vestibular evoked myogenic potentials outcome parameters. [2011.04]
Motion-sickness medications for aircrew: impact on psychomotor performance. [2005.06]
Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness. [2004.09]
Emergency contraception. [2002.08.06]
Effects of vestibular rehabilitation on dizziness and imbalance. [1992.02]
The failure of antimotion sickness medication to improve reading in developmental dyslexia: results of a randomized trial. [1988.12]
Other research related to Antivert (Meclizine)
Biphasic dosing regimen of meclizine for prevention of postoperative nausea and
vomiting in a high-risk population. [2010]
Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine. [2009.11.15]
Meclizine in combination with ondansetron for prevention of postoperative nausea and vomiting in a high-risk population. [2007.02]
Physiological and behavioral effects of an antivertigo antihistamine in adults. [1999.06]
Other possibly related research studies
Effects of drug countermeasures for space motion sickness on working memory in humans. [2004.11]
Delivery outcome after the use of meclozine in early pregnancy. [2003]
Combined action of vasoactive amines and bradykinin mediates allergen-evoked thermal hyperalgesia in rats. [2003.02.21]
Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays. [2002.10.29]
Equipment for drug release testing of medicated chewing gums. [2000.04]
Apparatus for studying in vitro drug release from medicated chewing gums. [1999.10.28]
Nefazadone-induced acute dystonic reaction. [1999.10]
Psychophysiological aspects of motion sickness. [1997.12]
Approach to the dizzy patient. [1994.11]
Suppression by cetirizine of pleurisy triggered by antigen in actively sensitized rats. [1992.11.13]
Dramatic favorable responses of children with learning disabilities or dyslexia and attention deficit disorder to antimotion sickness medications: four case reports. [1991.12]
Effect of PAF-acether antagonists on active anaphylactic mouse paw edema. [1991.12]
Pro-inflammatory activity of enterolobin: a haemolytic protein purified from seeds of the Brazilian tree Enterolobium contortisiliquum. [1991]
Formalin injection into knee joints of rats: pharmacologic characterization of a deep somatic nociceptive model. [2006.02]
Antihistamines in the treatment of dermatitis. [2003.11]
Serotonin reuptake inhibitors for dizziness with psychiatric symptoms. [2002.05]
Role of mast cells in the development of pancreatitis-induced multiple organ dysfunction. [2002.02]
Managing space motion sickness. [1998.01]
Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies. [1997.06]
No causal relationship between transdermal scopolamine and seizures: methodologic lessons for pharmacoepidemiology. [1991.07]
Effect of azelastine on platelet-activating factor and antigen-induced pleurisy in rats. [1991.05.17]
Suncus murinus as a new experimental model for motion sickness. [1988]
Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications. [2006]
Airsickness prevention in helicopter passengers. [2007.04]
Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model. [2007.09.15]
Vertigo - part 2 - management in general practice. [2008.06]
Treating common ear problems in pregnancy: what is safe? [2008.02]
Maltodextrin: a novel excipient used in sugar-based orally disintegrating tablets and phase transition process. [2010.06]
Pharmaceutical countermeasures have opposite effects on the utricles and
semicircular canals in man. [2012]
Various anti-motion sickness drugs and core body temperature changes. [2011]
|
